The SynAD study aims to determine if daily treatment with an oral preparation containing healthy bacteria, given together with specific carbohydrates to help them thrive, is effective in reducing severity of atopic dermatitis (AD) in food allergic children aged between 6 months and 3 years.

Not Applicable

Withdrawn

• Conditions: Atopic dermatitis; Food allergy; Skin - Dermatological conditions; Diet and Nutrition - Other diet and nutrition disorders

• Registration Number: ACTRN12616001341415
• Lead Sponsor: niversity of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-09-26
• Last Update Posted: 28 June 2021

Recruitment & Eligibility

• Status: Withdrawn
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Age 6 – 36 months
Attending allergy clinic at Lady Cilento Children's Hospital
Have moderate-to-severe atopic dermatitis defined by SCORAD >25
Have at least one food allergy

Exclusion Criteria

Systemic antibiotics administered within the last 4 weeks. Oral or IV steroids administered within the last 4 weeks. (Inhaled and topical steroids are OK).
If these drugs are necessary during the intervention the trial will be ceased for that participant.
Co-existent chronic disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified